Medifast, Inc. (MED)
12.00
+0.05
(+0.42%)
USD |
NYSE |
Aug 24, 16:00
Medifast EPS Diluted (Quarterly) : -0.2784 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2784 |
| March 31, 2026 | -0.1928 |
| December 31, 2025 | -1.648 |
| September 30, 2025 | -0.2057 |
| June 30, 2025 | 0.2242 |
| March 31, 2025 | -0.0705 |
| December 31, 2024 | 0.0729 |
| September 30, 2024 | 0.1029 |
| June 30, 2024 | -0.7455 |
| March 31, 2024 | 0.7589 |
| December 31, 2023 | 0.552 |
| September 30, 2023 | 2.116 |
| June 30, 2023 | 2.774 |
| March 31, 2023 | 3.667 |
| December 31, 2022 | 2.412 |
| September 30, 2022 | 3.274 |
| June 30, 2022 | 3.420 |
| March 31, 2022 | 3.59 |
| December 31, 2021 | 2.908 |
| September 30, 2021 | 3.562 |
| June 30, 2021 | 3.960 |
| March 31, 2021 | 3.456 |
| December 31, 2020 | 2.358 |
| September 30, 2020 | 2.906 |
| June 30, 2020 | 1.856 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.563 |
| December 31, 2019 | 1.664 |
| September 30, 2019 | 1.318 |
| June 30, 2019 | 1.750 |
| March 31, 2019 | 1.695 |
| December 31, 2018 | 1.303 |
| September 30, 2018 | 1.139 |
| June 30, 2018 | 1.16 |
| March 31, 2018 | 1.01 |
| December 31, 2017 | 0.60 |
| September 30, 2017 | 0.55 |
| June 30, 2017 | 0.63 |
| March 31, 2017 | 0.51 |
| December 31, 2016 | 0.34 |
| September 30, 2016 | 0.51 |
| June 30, 2016 | 0.29 |
| March 31, 2016 | 0.36 |
| December 31, 2015 | 0.32 |
| September 30, 2015 | 0.46 |
| June 30, 2015 | 0.51 |
| March 31, 2015 | 0.36 |
| December 31, 2014 | -0.28 |
| September 30, 2014 | 0.39 |
| June 30, 2014 | 0.44 |
| March 31, 2014 | 0.45 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| United Natural Foods, Inc. | 0.5263 |
| Integrated BioPharma, Inc. | -0.027 |
| BioForce Nanosciences Holdings, Inc. | 0.0071 |
| Skinvisible, Inc. | -0.0473 |
| Nevis Brands, Inc. | -0.0043 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.10M |
| Revenue (Quarterly) | 76.38M |
| Total Expenses (Quarterly) | 79.48M |
| Enterprise Value | -8.031M |
| Gross Profit Margin (Quarterly) | 69.90% |
| Profit Margin (Quarterly) | -4.06% |
| Earnings Yield | -19.38% |
| Normalized Earnings Yield | -17.68 |